Article
OIG Expects Tighter Control on Compounded Drugs in CMS-Approved Hospitals
OIG recommends training for inspectors and amending contracts with stand-alone pharmacies to ensure improved quality and safety.
More than 2 years after drugs contaminated with a virulent fungus killed 64 patients and caused related illnesses in another 687, Medicare-approved hospital accreditors still don't properly oversee contracts hospitals have with compounding pharmacies to assure these drugs are safe, according to an Office of Inspector General report.
It recommends CMS consider requiring 55 practices to use accreditors to oversee compounded sterile preparations.
Link to the complete article on Medpage Today: http://bit.ly/1uY91MX
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
